Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
The Finnish Diabetes Risk Score (FINDRISC), incident diabetes and low-grade inflammationAntonio E Pesaro Márcio Sommer Bittencourt; Marcelo Franken; José A M Carvalho; Daniel Bernardes; Jaakko Tuomilehto; Raul D SantosDiabetes Research and Clinical Practice Amsterdam v. 171, p. 108558, jan. 2021Amsterdam 2021Online access. The library also has physical copies. |
2 |
Material Type: Article
|
![]() |
Incidence of childhood type 1 diabetes worldwideMarjata Karnoven Maarit Viik-Kajander; Elena Moltchanova; Ingrid Libman; Ronald LaPorte; Jaakko Tuomilehto; Laércio Joel FrancoDiabetes Care Alexandria v. 23, n. 10, p. 1516-1526, 2000Alexandria 2000Available at FMRP - Fac. Medicina de Ribeirão Preto (pcd 1198749 )(GetIt) |
3 |
Material Type: Article
|
![]() |
Incidence of childhood type 1 diabetes worldwideMarjata Karnoven Maarit Viik-Kajander; Elena Moltchanova; Ingrid Libman; Ronald LaPorte; Jaakko Tuomilehto; Laércio Joel FrancoDiabetes Care Alexandria v. 23, n. 10, p. 1516-1526, 2000Alexandria 2000Available at FMRP - Fac. Medicina de Ribeirão Preto (pcd 1198749 )(GetIt) |
4 |
Material Type: Article
|
![]() |
Impact of age on the efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemiaHenry N Ginsberg Jaakko Tuomilehto; G. Kees Hovingh; Bertrand Cariou; Raul Dias dos Santos Filho; Alan S Brown; Santosh K Sanganalmath; Andrew Koren; Desmond Thompson; Frederick J RaalCardiovascular drugs and therapy v. 33, n. 1, p. 69-76, 2019Dordrecht 2019Online access. The library also has physical copies. |
5 |
Material Type: Article
|
![]() |
Treatment effect of alirocumab according to age group, smoking status, and hypertension pooled analysis from 10 randomized ODYSSEY studiesFrederick J Raal Jaakko Tuomilehto; Andrei C Sposito; Francisco A Fonseca; Maurizio Averna; Michel Farnier; Raul Dias dos Santos Filho; Keith C Ferdinand; R. Scott Wright; Eliano Pio NavareseJournal of clinical lipidology v. 13, n. 5, p. 735-743, 2019New York 2019Online access. The library also has physical copies. |
6 |
Material Type: Article
|
![]() |
The circadian syndrome predicts cardiovascular disease better than metabolic syndrome in Chinese adultsShi, Z. ; Tuomilehto, J. ; Kronfeld‐Schor, N. ; Alberti, G. K. ; Stern, N. ; El‐Osta, A. ; Bilu, C. ; Einat, H. ; Zimmet, P.Journal of internal medicine, 2021-06, Vol.289 (6), p.851-860 [Peer Reviewed Journal]England: Blackwell Publishing LtdFull text available |
7 |
Material Type: Article
|
![]() |
Metabolomic response to coffee consumption: application to a three‐stage clinical trialCornelis, M. C. ; Erlund, I. ; Michelotti, G. A. ; Herder, C. ; Westerhuis, J. A. ; Tuomilehto, J.Journal of internal medicine, 2018-06, Vol.283 (6), p.544-557 [Peer Reviewed Journal]England: Blackwell Publishing LtdFull text available |
8 |
Material Type: Article
|
![]() |
Post-stroke cognitive decline: an update and perspectives for clinical researchBrainin, M. ; Tuomilehto, J. ; Heiss, W.-D. ; Bornstein, N. M. ; Bath, P. M. W. ; Teuschl, Y. ; Richard, E. ; Guekht, A. ; Quinn, T.European journal of neurology, 2015-02, Vol.22 (2), p.229-e16 [Peer Reviewed Journal]England: Blackwell Publishing LtdFull text available |
9 |
Material Type: Article
|
![]() |
Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)Lindström, J. ; Peltonen, M. ; Eriksson, J. G. ; Ilanne-Parikka, P. ; Aunola, S. ; Keinänen-Kiukaanniemi, S. ; Uusitupa, M. ; Tuomilehto, J.Diabetologia, 2013-02, Vol.56 (2), p.284-293 [Peer Reviewed Journal]Berlin/Heidelberg: Springer-VerlagFull text available |
10 |
Material Type: Article
|
![]() |
Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic studyAHTILUOTO, S ; POLVIKOSKI, T ; PELTONEN, M ; SOLOMON, A ; TUOMILEHTO, J ; WINBLAD, B ; SULKAVA, R ; KIVIPELTO, MNeurology, 2010-09, Vol.75 (13), p.1195-1202 [Peer Reviewed Journal]Hagerstown, MD: Lippincott Williams & WilkinsFull text available |